Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ceftobiprole in acute bacterial skin and skin structure infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• ceftobiprole (ceftobiprole)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Status: COMPLETED | Results posted: 2020-05-18